EGFR gene is amplified in 40% of the malignant gliomas and about one half of these glioma cells have a mutant form of the receptor (EGFRvIII) that lacks the ligand-binding domain, thus becoming constitutively active [6]. Here, EGFR is linked to central nervous system cancer.